Insider Transactions Reported by 17 Insiders of PMV Pharmaceuticals, Inc.

Symbol
PMVP on Nasdaq
Location
Princeton, NJ

Insiders trading volume in the past year

PMV Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
INTERWEST PARTNERS X LP 10%+ Owner $10,040,531 13 Jul 2021
ORBIMED ADVISORS LLC 10%+ Owner $7,562,442 -$2,420,000 -24% 23 Oct 2025
Thilo Schroeder Director $2,455,861 06 Oct 2021
David Henry Mack President and CEO, Director $697,788 -$62,179 -8.2% 27 Oct 2025
Euclidean Capital LLC 10%+ Owner $283,431 11 Jun 2021
Robert Ticktin General Counsel & COO $105,090 -$24,651 -19% 01 Jul 2025
Leila Alland Chief Medical Officer $102,377 15 Sep 2023
Deepika Jalota Chief Development Officer $95,761 -$35,198 -27% 01 Jul 2025
Michael Carulli Chief Financial Officer $64,037 -$30,077 -32% 01 Jul 2025
Winston Kung Coo, Cfo $23,638 12 May 2023
KIRSTEN FLOWERS Director 05 Jun 2025
CHARLES M. BAUM Director 05 Jun 2025
Peter A. Thompson Director, 10%+ Owner 02 Jun 2021
Richard A. Heyman Director 05 Jun 2025
Carol Giltner Gallagher Director 05 Jun 2025
Laurie Stelzer Director 05 Jun 2025
ARNOLD J. LEVINE Director 05 Jun 2025

Recent Insider Transactions by Companies or Individuals for PMV Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.